The English word “resist” means “to resist.” In Hanover, this term is a major focus for scientists at Leibniz University: The Resist research group is investigating which factors enable some people to fight off infections more effectively than others. The goal is to gain new insights into the immune system and use them to develop innovative approaches to prevention and treatment.
At the TWINCORE Center for Experimental and Clinical Infection Research in Hanover, a rapid test is currently being developed that can detect the RS virus immediately after birth. Such diagnostic methods help identify infections early and treat them effectively.
For the startup Syntellix AG in Hanover, the concept of “resistance” also plays an important role. The company develops specialized implants that are inserted after bone fractures and dissolve on their own inside the body. This helps reduce the risk of infection and supports the healing process.
Research and development in Hanover demonstrates how closely science, medicine, and industry collaborate to create innovative solutions in the field of infection control and to improve health care in a sustainable manner.